New: NCI-funded clinical trial search
Mednet Logo
SpecialtiesHospital Medicine
Hospital Medicine

Hospital Medicine

Physician discussions on inpatient care, transitions of care, diagnostic reasoning, and hospital-based protocols.

Recent Discussions

What is the importance of finding a positive titer for TS-HDS and what treatment would be advised for these patients?

1
2 Answers

Mednet Member
Mednet Member
Neurology · University of Minnesota

TS-HDS antibodies were first described by investigators from Washington University in St. Louis (2003) in five patients with painful sensory axonal neuropathy [1]. Further studies by the same group indicated that TS-HDS antibodies were associated with prominent neuropathic pain in the upper extremit...

For patients with kidney stone disease and chronic kidney disease, is there an eGFR threshold at which you no longer recommend pursing 24 hour urine stone risk studies?

2 Answers

Mednet Member
Mednet Member
Nephrology · Medical College of Wisconsin

While I agree with Dr. @Dr. First Last's comments in general, though, I have encountered patients that newly presented for stone disease at late stages of CKD and even on dialysis. The critical consideration is whether there is evidence of ongoing stone formation/growth. We must be aware that a ston...

How do you approach hematuria in a patient with diabetic nephropathy?

3 Answers

Mednet Member
Mednet Member
Nephrology · Penn Medicine Cherry Hill

This is a difficult question to answer. If young, no risk factors for GU malignancy and only microscopic hematuria would generally not pursue but make patient aware of small risk and make sure PCP also knows. Helpful to know if red cells are dysmorphic and if there is also proteinuria. Gross hematur...

Would you recommend dual antiplatelet therapy or anticoagulation for a patient previously on aspirin who has a breakthrough stroke with history of CADASIL?

2
2 Answers

Mednet Member
Mednet Member
Neurology · University of Colorado, Climate & Health Dept

CADASIL is a genetic condition with a presumed mechanism of vascular injury to be disruption of the blood-brain barrier and non-atherosclerotic angiopathy. Thus, it makes sense that no anti-thrombotic has been show to reduce stroke risk. It's expert consensus to do daily aspirin, but this is more to...

How do you decide when to use andexanet (ANDEXXA) for intracranial hemorrhage associated with factor Xa inhibitors?

1
1 Answers

Mednet Member
Mednet Member
Neurology · HCA Houston Healthcare

The ANNEXA-I trial presents a mixed perspective. The data demonstrated that Andexanet is superior to standard care in reducing hematoma expansion for intracerebral hemorrhage associated with factor Xa inhibitors. This conclusion is based on an imaging-based primary endpoint, supported by previous st...

What is the role of non-prednisone oral glucocorticoids in the management of systemic rheumatologic disease?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Mobile Medical Care Inc

I saw this question and thought it was really interesting. I did some preliminary research on the topic and was amazed at how little is actually written in the scientific literature. Perhaps someone reading this can perform a search and offer some thoughts. I decided to write to start a dialogue on ...

For which patients with calciphylaxis would you recommend a parathyroidectomy?

4 Answers

Mednet Member
Mednet Member
Nephrology · Harvard Medical School

In those with refractory hyperparathyroidism (typically PTH above 800-1000 pg/mL) despite medical therapies like cinacalcet.

How do you complete brain death testing in patients who cannot tolerate apnea testing and are unable to transport for ancillary testing?

3
5 Answers

Mednet Member
Mednet Member
Neurology · UC Davis Health

The short answer is that you cannot. Brain death diagnosis requires the presence of 3 conditions: persistent coma, absence of brainstem reflexes, and lack of ability to breathe independently. If portions of the clinical exam or apnea test cannot be performed, ancillary testing is necessary to make t...

Should you consider thromboprophylaxis, even for low-dose lenalidomide maintenance, post-autologous transplantation?

1 Answers

Mednet Member
Mednet Member
Medical Oncology · Dana-Farber Cancer Institute

In the event there are no adverse contraindications for the use of thromboprophylaxis, yes, I recommend the use of a minimum of 81 mg of aspirin daily with a low dose of lenalidomide. In this meta-analysis (Chakraborty et al., PMID 31913498), the risk of venous thromboembolism was low with a low dos...

What postural change in FVC is suggestive of respiratory muscle weakness?

2 Answers

Mednet Member
Mednet Member
Pulmonology · University of Michigan Hospitals and Health Centers

In our practice, an assisted ventilation clinic which is enriched with patients who have diagnosed neuromuscular disease and/or chronic respiratory failure of unclear etiology, we often use 12% or 200cc simply by analogy to the criteria we use to assess bronchodilator responsiveness during PFTs. Alt...